This is where we share the valuable insights we've learned from our years of experience in decentralized clinical trials. Scroll down to see our latest content.
ePROs, or electronic patient-reported outcomes, play an essential role in clinical trials, illuminating patients' lived experiences.
Let’s dive into how decentralized clinical trials (DCTs), leveraging a modular approach, can address four key challenges in central nervous system research
Many clinical trial sponsors don’t understand how decentralized clinical trials (DCTs) fit within today’s regulatory landscape. This lack of familiarity with decentralized research and regulatory approaches has created DCT hesitancy among sponsors.
Patient engagement in clinical trials can make or break a study. Engaged patients are more likely to participate and complete studies, which can strengthen data collection and, ultimately, provide more robust therapeutic evidence of safety and efficacy.